Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,822,656 papers from all fields of science
Search
Sign In
Create Free Account
CpG 7909
Known as:
CpG-7909
, CpG7909
A synthetic 24-mer oligonucleotide containing 3 CpG motifs with potential antineoplastic and immunostimulatory activity. CpG 7909 selectively targets…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Agatolimod Sodium
Narrower (1)
PF 3512676
Broader (1)
ProMune
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Tumor-reactive CD8 1 T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide V
J. Karbach
,
S. Gnjatic
,
+7 authors
N. Altorki
2010
Corpus ID: 79520993
Peptide-based vaccines have led to the induction of antigen-specific CD8 1 T-cell responses in patients with NY-ESO-1 positive…
Expand
2008
2008
Clinical and immunologic responses to a novel in situ lymphoma vaccine maneuver: Preliminary results of a phase II trial of intra-tumoral CpG 7909
J. Brody
,
Wei-Yun Z. Ai
,
+4 authors
R. Levy
2008
Corpus ID: 78651247
3003 Background: Lymphoma vaccines have shown preliminary clinical success, but their development has been slowed by the…
Expand
2006
2006
Survivin: preclinical rationale and preliminary clinical results
J. Becker
,
M. Wobser
,
P. Straten
,
M. R. Andersen
2006
Corpus ID: 71242067
Background Vaccination with MAGE peptides is followed by tumor regression in 10–20% of metastatic melanoma patients with…
Expand
2006
2006
Phase I/II study of immunization with eight peptides mixed with CpG7909 in HLA-A2 patients with metastatic melanoma
J. Baurain
,
M. Marchand
,
+5 authors
P. Coulie
2006
Corpus ID: 71250589
2005
2005
Combination of a Toll-like receptor 9 (TLR9) agonist, CPG 7909 (CPG) with first line taxane/platinum improves response rate in late stage non-small-cell lung cancer (NSCLC)
C. Manegold
,
J. Mezger
,
+4 authors
T. Schmalbach
2005
Corpus ID: 80426293
2005
2005
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2005
Corpus ID: 28713703
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2004
2004
TLR9 Agonist Immunomodulator Treatment of Cutaneous T-Cell Lymphoma (CTCL) with CPG7909.
Youn H. Kim
,
M. Girardi
,
+7 authors
T. Schmalbach
2004
Corpus ID: 78415565
CPG 7909 belongs to a new class of chemically defined CpG immunomodulators that target dendritic cell TLR9 receptors inducing IL…
Expand
2004
2004
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2004
Corpus ID: 44918236
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2003
2003
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2003
Corpus ID: 32643595
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand